Puma Biotechnology
PBYI
PBYI
158 hedge funds and large institutions have $1.32B invested in Puma Biotechnology in 2019 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 52 increasing their positions, 44 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
18% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 44
12% more funds holding
Funds holding: 141 → 158 (+17)
3.55% less ownership
Funds ownership: 92.29% → 88.74% (-3.5%)
Holders
158
Holding in Top 10
4
Calls
$33.2M
Puts
$20.1M
Top Buyers
| 1 | +$101M | |
| 2 | +$30.5M | |
| 3 | +$16.5M | |
| 4 |
FAM
Fred Alger Management
New York
|
+$14.3M |
| 5 |
Goldman Sachs
New York
|
+$14.2M |
Top Sellers
| 1 | -$42.2M | |
| 2 | -$27.9M | |
| 3 | -$26.5M | |
| 4 |
MAM
Melqart Asset Management
London,
United Kingdom
|
-$23.6M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$19.9M |